PhAc-ALGP-Dox

N/A

Report date: 2026/01/13 17:57:01
NME

Base Information

Drug NamePhAc-ALGP-Dox
Drug Alias NamePhAc-ALGP-Dox
ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)
Mechanisms of ActionDNA topoisomerase I inhibitors
TargetsDNA topoisomerase I
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Leuven
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Leuven
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A